Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Descripción completa

Detalles Bibliográficos

Autores principales:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2006-04-01
Colección:	AIDS Research and Therapy
Acceso en línea:	http://www.aidsrestherapy.com/content/3/1/11
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!